Leserbrief
Severe Cutaneous Adverse Reactions in the Setting of Antineoplastic Therapy: A Single-Institution Retrospective Study
Cutis · 01.03.2026 · 3 (117)
DOI: 10.12788/cutis.1368 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cutis, erschienen am 01.03.2026. Verfasst von Kailyn Valido und 2 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, Connecticut. Drs. Leventhal and Nelson are from the Department of Dermatology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Yale School of Medicine, New Haven, Connecticut. Drs. Leventhal and Nelson are from the Department of Dermatology.
Zitieren
APA
Valido, K., Leventhal, J. S., & Nelson, C. A. (2026). Severe Cutaneous Adverse Reactions in the Setting of Antineoplastic Therapy: A Single-Institution Retrospective Study. Cutis, 3(117). https://doi.org/10.12788/cutis.1368
Vancouver
Valido K, Leventhal JS, Nelson CA. Severe Cutaneous Adverse Reactions in the Setting of Antineoplastic Therapy: A Single-Institution Retrospective Study. Cutis. 2026;3(117). doi:10.12788/cutis.1368
BibTeX
@article{Valido2026,
author = {Valido, Kailyn and Leventhal, Jonathan S and Nelson, Caroline A},
title = {Severe Cutaneous Adverse Reactions in the Setting of Antineoplastic Therapy: A Single-Institution Retrospective Study},
journal = {Cutis},
year = {2026},
volume = {3},
number = {117},
doi = {10.12788/cutis.1368}
}
EUVIMED